Inovio Pharmaceuticals Inc (INO)

Finanzdaten der Inovio Pharmaceuticals Inc-Aktie (INO)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
	15.15%18.62	21.95	17.48	21.21	23.08
Research and Development	23.05%10.83	14.07	10.26	13.33	14.52
Operating Income/Loss	15.15%-18.62	-21.95	-17.48	-21.21	-23.08
	69.45%-6.01	-19.68	3.76	-45.50	-23.52
Attributable To Parent	69.45%-6.01	-19.68	3.76	-45.50	-23.52
Basic Average Shares	18.11%81.62	69.10	-	52.17	38.83
Diluted Average Shares	18.11%81.62	69.10	-	52.17	38.83
Basic Earnings Per Share	75.00%-0.07	-0.28	-	-0.87	-0.61
Diluted Earnings Per Share	75.00%-0.07	-0.28	-	-0.87	-0.61